Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.
about
Tamoxifen for induction of Cre-recombination may confound fibrosis studies in female mice.Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1).Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer.Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain ManagementBoronic prodrug of endoxifen as an effective hormone therapy for breast cancer.Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomes.Tamoxifen metabolite endoxifen interferes with the polyamine pathway in breast cancer.Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism?Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients.CYP450 genotype and pharmacogenetic association studies: a critical appraisal
P2860
Q33714763-8C54DB0C-919A-472C-BF8E-FC54E4836D85Q34360041-45BD9F42-7B5C-42D1-BDA8-6732FE61384AQ35020403-3E0ED578-5A7D-45DD-B68E-6FFE78C5CEAAQ35732619-DA4CB24B-8153-40D1-9C6F-87B0E0214D52Q35909069-B51DBE59-8717-405D-8B4A-5740D7120AD4Q35915042-774E5207-6CE7-4096-86A4-907CD666879EQ38649909-B115F25E-BB02-4E7D-A197-7290D5D8E9F8Q39580768-B24D7336-4ED4-4906-A213-1007ED23E4C3Q39864884-6539EA82-39BA-419D-8297-9F9DF6101041Q50625597-17EBCC63-1EB0-4B31-9273-2FF87FCB79D7Q57585515-06A41B25-3986-44E7-8F49-D7932B833885
P2860
Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Personalized medicine in breas ...... d CYP2D6 in clinical practice.
@en
type
label
Personalized medicine in breas ...... d CYP2D6 in clinical practice.
@en
prefLabel
Personalized medicine in breas ...... d CYP2D6 in clinical practice.
@en
P2093
P2860
P1476
Personalized medicine in breas ...... d CYP2D6 in clinical practice.
@en
P2093
Alan H B Wu
Ann H Partridge
Eric P Winer
Erica L Mayer
Harold J Burstein
Kathryn J Ruddy
Rebecca S Gelman
Rinaa S Punglia
Sara M Tolaney
Stephen D Desantis
P2860
P2888
P304
P356
10.1007/S10549-013-2700-1
P407
P577
2013-09-24T00:00:00Z
P6179
1052355153